CSafe LLC, provider of active container systems for the temperature-sensitive airfreight market, confirmed the successful Operational Qualification (OQ) of its AcuTemp RKN air cargo container by three major pharmaceutical companies.
Each company performed independent testing of containers at a wide range of temperature requirements across multiple shipping lanes, ambient conditions, varying payload sizes, and shipment durations. Consistent and successful results of the testing process by all three companies identify the AcuTemp RKN as a qualified and reliable system for transporting temperature-sensitive healthcare products globally, particularly at 2° to 8° C and especially where extreme ambient temperatures are encountered.
The AcuTemp RKN air cargo container is designed to eliminate the challenges associated with maintaining the cold chain for shipping temperature-sensitive pharmaceuticals and biotechnology products. These products are often highly susceptible to damage or compromise due to insufficient temperature management as a result of inadequate packaging for the encountered ambient temperature conditions, dry ice irregularities, and transit delays. CSafe addresses these issues with its AcuTemp RKN, which provides superior thermal efficiency, compressor-driven technology, and qualified operating capabilities for extended periods.
The OQ process employed for qualifying an active cooling and heating container along with the performance merits of the AcuTemp RKN were highlighted at IQPC’s seventh Cold Chain Distribution for Pharmaceuticals conference.
“We are happy to report that the day-to-day working performance of the AcuTemp RKN accurately mirrors the performance and reliability testing performed by several large pharmaceutical and biotechnology companies,” said Oliver Bootz, vice-president of business development for CSafe.
For more information, visit www.csafellc.com.
